Information about Gefitinib
Gefitinib is used in the treatment of non-small cell lung cancer. It is used in patients in which it has spread to other parts of the body, who have abnormal epidermal growth factor receptor (EGFR) genes, and who have not had previous treatment for cancer.
How gefitinib works
Gefitinib is an anti-cancer medication. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.
Common side effects of gefitinib
Nausea, Rash, Vomiting, Weakness, Loss of appetite, Dry skin, Diarrhea, Stomatitis (Inflammation of the mouth)
Available Medicine for Gefitinib
- ₹1966 to ₹5900Natco Pharma Ltd2 variant(s)
- ₹4500 to ₹9990Celon Laboratories Ltd2 variant(s)
- ₹3154Hetero Drugs Ltd1 variant(s)
- ₹3706Intas Pharmaceuticals Ltd1 variant(s)
- ₹4023Dr Reddy's Laboratories Ltd1 variant(s)
- ₹3002Zuventus Healthcare Ltd1 variant(s)
- ₹3400United Biotech Pvt Ltd1 variant(s)
- ₹4309Glenmark Pharmaceuticals Ltd1 variant(s)
- ₹1555 to ₹4586Cipla Ltd2 variant(s)
- ₹3445Panacea Biotec Ltd1 variant(s)
Expert advice for Gefitinib
- Gefitinib helps treat non-small cell lung cancer that is locally advanced, or has spread to other areas of the body.
- Take it with or without food, preferably at the same time each day.
- Do not take antacids (to reduce the acid level of your stomach) 2 hours before or 1 hour after taking this medicine.
- Diarrhea may occur as a side effect. Drink plenty of fluids and inform your doctor if it doesn't stop or if you find blood in your stools.
- Use a reliable contraceptive method to prevent pregnancy while you are taking this medicine and for a month after you stop taking it.
- Inform your doctor if you develop ulceration in your mouth, changes in your vision or if you experience a worsening cough, shortness of breath, or breathing difficulties while taking this medicine.
- Your doctor may want you to have regular blood tests to monitor your liver function while you are having treatment with this medicine.
Frequently asked questions for Gefitinib
Q. Is Gefitinib a monoclonal antibody?
No. It is not a monoclonal antibody.It is a tyrosine kinase inhibitors.